The American Society of Clinical Oncology and the National Comprehensive Cancer Network have collaborated to develop seven evidence-based quality measures for breast and colorectal cancers. The ASCO/NCCN Quality Measures can be applied to assess the extent to which oncologists are providing quality care to their patients. The measures and their specifications are available on-line at www.asco.org/qualitymeasures and www.nccn.org.
They are appropriate for diverse measurement uses, including provider self-assessment, quality improvement programs and external quality monitoring. If appropriately implemented, the quality measures could serve as tools for future pay-for-reporting programs.
The Measures address processes of care that have been linked to patient outcomes, including survival, and apply to large numbers of cancer patients and target areas in which variation in care has been demonstrated.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze